Morphological features of tumor in different treatment options for patients With Locally Advanced Breast Cancer
DOI:
https://doi.org/10.47494/mesb.v7i.151Keywords:
Morphological structure, locally advanced breast cancerAbstract
Despite significant advances in the early diagnosis and treatment of locally advanced breast cancer, 60–65% of the Republic of Uzbekistan is accounted for by locally advanced breast cancer and its mortality rate is high. The morphological structure of breast cancer is important for the prognosis of the disease. On cell membranes there are special cytoplasmic proteins - receptors, which, when combined with hormones, can affect the rate of division of tumor cells. In terms of the choice of treatment options and the assessment of the forecast, some molecular genetic parameters of the tumor are important, among which, first of all, the hormonal status of the tumor (ER / PR), HER-2 / neu, p53, Bcl-2, Ki-67
Downloads
References
Bozhok AA, Semiglazov VF, Semiglazov VV Prognosis factors in breast cancer // Modern Oncology.-2005.-№1-С.4-9.
Zaridze, D.G. Carcinogenesis / D.G. Zaridze. - M: Medicine, 2004 .-- 576 p.
Muratkhodzhaev N.K., Kosimov D.A. Breast cancer in Uzbekistan (statistical analysis) .- Tashkent, 2005.-P.428-429.
Musabayeva A.I., Zhogina J.A., Slonimskaya E.M. The role of modern methods of radiation therapy in the complex treatment of patients with locally advanced forms of breast cancer // Materials of the I Congress of Oncologists of the Republic of Uzbekistan-Tashkent, 2005.-С 428 -429.5. Moiseenko, V.M. Modern drug treatment of locally spread and meta static burn of the mammary gland / V.M. Moiseenko, V.F. Semiglazov, S.A. Tyulandin. - SPb .: Grifon, 1997 .-- 254 p.
S.M. PORTNOY Russian Cancer Research Center named after N.N. blokhinARAMN", Moscow || TREATMENT OF LOCALLY ADVANCED BREAST CANCER-SIBERIAN ONCOLOGICAL JOURNAL. 2008. Appendix No. 2
Khorov A.O., K.N. Uglyanitsa, A.K. Grib - Journal of Grodno State Medical University No. 3 2012 -29-30 pages8 .Arens, N. HER2/neu, p53, Ki6 7, and hormone receptors do not change du ring neoadjuvant chemotherapy in breast ca ncer / N. Arens, U. Bleyl, R. Hildenbrand // Virchows Arch. -2005. – Vol. 446. – P. 48 9-49 6.
Comparison of estrogen receptor, progesterone receptor and Her-2 status in breast cancer pre- and post-neoadjuvant chemotherapy / M. Kasami [et al.] // Breast. – 2008. - Vol. 17. – P. 523-527.
Evaluation of the United States Food and Drug Administration- a pproved scoring a nd test system of H ER-2 protein expression in breast cancer / P. Birner [et al.] // Clin. Cancer Res. – 2001. – Vol. 7, № 6. – P. 1669-1 675.
Hamilton, A. The contribution of molecular markers to the prediction of response in the treatment of breast cancer: A review of the literature on HER-2, p53and BCL-2 / A. Hamilton, M. Piccart // Ann. Oncol. -2000. – Vol. 11, №6. – P. 647-663.
Hung, M.C. Basic science of HER-2/neu: a review / M.C. Hung, Y.K. Lau // Semin. Oncol. – 1999. – Vol. 26, № 4. – P. 51-59. 1 4 .Joensuu, H. BcI-2 protein expression and long-term survival in breast cancer / H. Joensuu, L. PyIkkanen, S. Toikkanent // Am. J. Pathology – 1994. – Vol. 145, № 5. – P. 1191 – 1198.
Negative steroid receptors are a good predictor for response to preoperative chemotherapy in breast ca ncer (BC) – results of a randomized trial / M. Untch [et al.] // Proc. Am. Soc. Oncol. – 2003. - Vol. 22 (abstract 35).
Pa letta , C.E. T he inferiorglu tea l free fla p in breast reconstruction / C.E. Paletta, J. Bostwick, F. Nahai // Plast. reconstr. Surg. – 1989. – Vol. 84. – P. 875.
Prognostic significance of Bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy / K.H. Lee [et al.] / / BMC Cancer. – 2007. – Vol. 7. – P.63.
Prognostic valu e of Ki-6 7 expression a fter short-term presurgica l endocrine therapy for prima rybreast ca ncer / W.J . Hrushesky [et al.] // J. Natl. Cancer Inst. – 2007. – Vol. 99, № 13. – P. 1 0 53 . 2 5 .T he effect of neoadjuvantchemotherapy on estrogen and progesterone receptor expression a nd hormone receptor statu s in breast cancer / S.H. Lee [et al.] // Am. J Surg. – 2003. - Vol. 186. – P. 3 4 8 -3 5 0 .
Progestin a ction and progesterone receptor structu re in human breast cancer: a review / K.B. Horwitz [et al.] // Recent Prog. Horm.Res. — 1985. — Vol. 41. — Р. 249 – 316
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
The work simultaneously licensed under a Creative Commons Attribution 4.0 International License
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
-
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
